NDC codes

FDA NDC Directory
Product NDC (as listed)0023-9652Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00023-9652Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0023-9652-0100023965201000239652011 IMPLANT in 1 POUCH (0023-9652-01)Marketed from Mar 4, 2020
0023-9652-0300023965203000239652031 IMPLANT in 1 POUCH (0023-9652-03)Marketed from Mar 4, 2020 · Sample package

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Durysta
Generic name (nonproprietary)
bimatoprost
Active ingredients
Bimatoprost — 10 ug/1
Dosage form
Implant
Route
Intracameral
Labeler
Allergan, Inc.NDC labeler code 0023
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 211911
Marketing start
Listing expires
Other FDA classes
Prostaglandins (Chemical structure)
Identifiers
Product ID 0023-9652_0315cd41-0cc8-44c3-82fc-501832cdb855SPL ID 0315cd41-0cc8-44c3-82fc-501832cdb855SPL set ID 3f59da84-0bcc-4c84-b3e2-e215681ef341RxCUI 2286602, 2286607UNII QXS94885MZ
Pharmacologic class
Prostaglandin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400023965201 followed by a unit qualifier and the quantity

Package 00023-9652-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

DURYSTA ® (bimatoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT). DURYSTA is a prostaglandin analog indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0023-9652

What is NDC 0023-9652?
0023-9652 is the product NDC for Durysta (bimatoprost), Bimatoprost 10 ug/1 implant, listed with the FDA by Allergan, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Durysta (Bimatoprost).
What is the active ingredient?
Bimatoprost.
Who is the labeler?
Allergan, Inc., NDC labeler code 0023. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Durysta?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in